Header Logo

Connection

MICHAEL SCHEURER to Bevacizumab

Back to Details
This is a "connection" page, showing publications MICHAEL SCHEURER has written about Bevacizumab.
MICHAEL SCHEURER
Connection Strength
0.239
Bevacizumab
  1. Clinical and genetic markers of vascular toxicity in glioblastoma patients: Insights from NRG Oncology RTOG-0825. Neuro Oncol. 2025 Mar 07; 27(3):767-778.
    View in: PubMed
    Score: 0.239
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.